08/31/2026
As one of three U.S. research sites participating in an FDA trial, Kessler Foundation helped evaluate the safety and everyday use of Eve, the first self-balancing personal exoskeleton cleared by the FDA for eligible wheelchair users with spinal cord injury.
The device is designed to help users stand, walk, and complete certain daily activities without using their hands for balance.
Learn more about Kessler Foundation’s role in this advancement: https://kesslerfoundation.org/In-The-News/fda-clears-first-self-balancing-personal-exoskeleton-people-spinal-cord-injury